Last week the FDA granted Eli Lilly emergency use authorization for their monoclonal antibodies to be used on children 12 and under. It is important to note that this treatment is also available for adults. In this video I will cover everything you need to know about these monoclonal antibodies (BAMLANIVIMAB & ETESEVIMAB). First, I will explain how they work in the body (mechanism of action). Second, I will go over the clinical trials that enabled Eli Lilly to receive emergency use authorization for this treatment. Third and finally, I will explain who is eligible to receive this drug. Watch the video by click above ☝🏻.
Feel free to like & comment below! Also, if you feel someone you know could benefit from watching this video, click the share button below👇🏻.
RESEARCH:
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2102685?articleTools=true
https://www.nature.com/articles/s41577-021-00542-x
LETS CONNECT: